Home / TXMD : NASDAQ

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does TXMD make money? Does TXMD have pricing power? What's the Earnings Whisper? Will TXMD profit more as the business scales? What is TXMD's management track record? Is TXMD's current price justified?

TherapeuticsMD, Inc.

$2.16 +$0.51 (+30.91%)

NASDAQ · 14 Sep 2026 20:00 UTC

Previous Close

$2.16

Day Range

$2.16$2.17

Year Range

$0.99$2.95

Market Cap

25M

AVG Volume

36.25K

Trailing/Forward PE

-114.89/11.37

PEG ratio

-9.77

Dividend Yield

Next Earnings Date

2026-11-17

Primary Exchange

NASDAQ

Revenue (USD)

TXMD Revenue (USD) by year
Period	Revenue (USD)
2025	3.02M
2024	1.76M
2023	1.3M
2022	69.96M
2021	86.95M
2020	64.87M
2019	49.65M
2018	16.1M
2017	16.78M
2016	19.36M

Net Income (USD)

TXMD Net Income (USD) by year
Period	Net Income (USD)
2025	-569K
2024	-2.18M
2023	-10.28M
2022	-21.72M
2021	-172.41M
2020	-183.52M
2019	-176.14M
2018	-132.62M
2017	-76.93M
2016	-89.88M

Operating Income (USD)

TXMD Operating Income (USD) by year
Period	Operating Income (USD)
2025	-4.21M
2024	-5.11M
2023	-8.52M
2022	45.76M
2021	-139.77M
2020	-155.54M
2019	-151.21M
2018	-130.22M
2017	-77.63M
2016	-90.25M

EBITDA (USD)

TXMD EBITDA (USD) by year
Period	EBITDA (USD)
2025	-3.55M
2024	-2.98M
2023	-6.62M
2022	59.1M
2021	-145.75M
2020	-150.83M
2019	-157.39M
2018	-127.65M
2017	-77.1M
2016	-90.12M

Cash Flows (USD)

TXMD Cash Flows (USD) by year
Period	Cash Flows (USD)
2025	2.42M
2024	732K
2023	-40.3M
2022	156.41M
2021	-144.54M
2020	-161.03M
2019	-169.22M
2018	-128.13M
2017	-76.98M
2016	-70.38M

EPS (USD)

TXMD EPS (USD) by year
Period	EPS (USD)
2025	-0.05
2024	-0.19
2023	-1.01
2022	-2.63
2021	-21.73
2020	-33.35
2019	-35.71
2018	-29.36
2017	-18.67
2016	-22.92

Expenses (USD)

TXMD Expenses (USD) by year
Period	Expenses (USD)
2025	6.85M
2024	5.37M
2023	1.06M
2022	57.96M
2021	209.73M
2020	202.2M
2019	197.42M
2018	164.61M
2017	92.38M
2016	106.53M

Cash & Debt (USD)

TXMD Cash & Debt (USD) by year
Period	Cash & Debt (USD)
2025	7.48M
2024	5.06M
2023	4.33M
2022	38.07M
2021	64.91M
2020	80.49M
2019	160.83M
2018	161.61M
2017	127.14M
2016	131.53M

Debt ratios

TXMD Debt ratios by year
Period	Debt ratios
2025	-0.03
2024	-0.02
2023	-0.02
2022	0.07
2021	-0.23
2020	-0.33
2019	-0.1
2018	0.23

Margins

TXMD Margins by year
Period	Margins
2025	100%
2024	100%
2023	51.08%
2022	75.96%
2021	78.33%
2020	75.37%
2019	87.24%
2018	83%
2017	84.28%
2016	78.38%

Return on Capital

TXMD Return on Capital by year
Period	Return on Capital
2025	-2.12%
2024	-7.97%
2023	-35.09%
2022	-61.8%
2021	184.16%
2020	148%
2019	-1914.39%
2018	-135.98%
2017	-59.21%
2016	-70.5%

Shares Outstanding

TXMD Shares Outstanding by year
Period	Shares Outstanding
2025	11.57M
2024	11.53M
2023	11.53M
2022	9.37M
2021	8.55M
2020	5.58M
2019	5.24M
2018	4.77M
2017	4.33M
2016	3.93M

Book Value Per Share (USD)

TXMD Book Value Per Share (USD) by year
Period	Book Value Per Share (USD)
2025	2.32
2024	2.37
2023	2.54
2022	3.75
2021	-10.95
2020	-22.24
2019	1.76
2018	20.44
2017	30.01
2016	32.42

Total Assets (USD)

TXMD Total Assets (USD) by year
Period	Total Assets (USD)
2025	37.66M
2024	38.82M
2023	43.31M
2022	90.46M
2021	169.47M
2020	181.61M
2019	265.99M
2018	211.98M
2017	143.23M
2016	142.47M

Employee Count

TXMD Employee Count by year
Period	Employee Count
2025	1
2024	1
2023	1
2022	1
2021	416
2020	400
2019	348
2018	241
2017	173
2016	159

PE Ratio

TXMD PE Ratio by year
Period	PE Ratio
Aug 26	133.84
Jul 26	131.26
Jul 26	133.2
Jul 26	133.2
Jul 26	129.32
Jul 26	136.43
Jun 26	136.43
Jun 26	126.09
Jun 26	142.25
Jun 26	128.67
May 26	138.37
May 26	137.08
May 26	129.32
Mar 26	80.48
Mar 26	85.85
Mar 26	83.16
Mar 26	86.23
Feb 26	86.61
Feb 26	88.15
Feb 26	90.45
Feb 26	87.76
Jan 26	82.78
Jan 26	100.03
Jan 26	85.46
Jan 26	82.78
Jan 26	63.24
Dec 25	66.68
Dec 25	65.15
Dec 25	67.07
Dec 25	66.68
Nov 25	65.15
Nov 25	68.22
Nov 25	75.12
Aug 23	0.83
Aug 23	0.89
Jul 23	0.84
Jul 23	0.88
Jul 23	0.82
Jul 23	0.85
Jun 23	0.86
Jun 23	0.85
Jun 23	0.81
Jun 23	0.85
Jun 23	0.92
May 23	0.81
May 23	0.91

Free Cash Flow Yield

TXMD Free Cash Flow Yield by year
Period	Free Cash Flow Yield
Sep 26	12.48%
Sep 26	12.48%
Sep 26	12.2%
Aug 26	12.14%
Aug 26	13.09%
Aug 26	13.02%
Aug 26	11.16%
Jul 26	11.38%
Jul 26	11.22%
Jul 26	11.22%
Jul 26	11.55%
Jul 26	10.95%
Jun 26	10.95%
Jun 26	11.85%
Jun 26	10.5%
Jun 26	11.61%
May 26	10.8%
May 26	10.9%
May 26	11.55%
May 26	10.58%
May 26	10.12%
Apr 26	9.57%
Apr 26	10.12%
Apr 26	10.12%
Apr 26	10.48%
Mar 26	8.51%
Mar 26	7.98%
Mar 26	8.23%
Mar 26	7.94%
Feb 26	7.91%
Feb 26	7.77%
Feb 26	7.57%
Feb 26	7.8%
Jan 26	8.27%
Jan 26	6.85%
Jan 26	8.01%
Jan 26	8.27%
Jan 26	10.83%
Dec 25	10.27%
Dec 25	10.51%
Dec 25	10.21%
Dec 25	10.27%
Nov 25	10.51%
Nov 25	10.04%
Nov 25	9.12%
Nov 25	5.2%
Oct 25	6.08%
Oct 25	5.61%
Oct 25	5.79%
Oct 25	6.95%
Oct 25	6.76%
Sep 25	6.76%
Sep 25	6.63%
Sep 25	6.52%
Sep 25	6.7%
Aug 25	6.52%
Aug 25	6.57%
Aug 25	6.18%
Aug 25	11.49%
Aug 25	10.97%
Jul 25	10.24%
Jul 25	10.59%
Jul 25	10.32%
Jul 25	10.32%
Jun 25	10.87%
Jun 25	11.17%
Jun 25	10.41%
Jun 25	9.74%
May 25	8.34%
May 25	8.4%
May 25	8.12%
May 25	4.35%
May 25	4.47%
Apr 25	5.43%
Apr 25	6.18%
Apr 25	6.31%
Apr 25	7.06%
Mar 25	6.36%
Mar 25	7.02%
Mar 25	8.61%
Mar 25	7.18%
Feb 25	6.71%
Feb 25	4.8%
Feb 25	6.06%
Feb 25	6.12%
Jan 25	5.78%
Jan 25	5.43%
Jan 25	5.89%
Jan 25	5.68%
Jan 25	4.25%
Dec 24	5.73%
Dec 24	5.62%
Dec 24	5.12%
Dec 24	5.08%
Nov 24	4.4%
Nov 24	4.56%
Nov 24	4.46%
Nov 24	-8.84%
Nov 24	-8.67%
Oct 24	-8.45%

Price to Sales

TXMD Price to Sales by year
Period	Price to Sales
Sep 26	7.65
Sep 26	7.65
Sep 26	7.82
Aug 26	7.86
Aug 26	7.29
Aug 26	7.33
Aug 26	7.15
Jul 26	7.01
Jul 26	7.11
Jul 26	7.11
Jul 26	6.9
Jul 26	7.28
Jun 26	7.28
Jun 26	6.73
Jun 26	7.59
Jun 26	6.87
May 26	7.39
May 26	7.32
May 26	6.9
May 26	7.58
May 26	7.92
Apr 26	8.38
Apr 26	7.92
Apr 26	7.92
Apr 26	7.66
Mar 26	8.69
Mar 26	9.27
Mar 26	8.98
Mar 26	9.31
Feb 26	9.36
Feb 26	9.52
Feb 26	9.77
Feb 26	9.48
Jan 26	8.94
Jan 26	10.8
Jan 26	9.23
Jan 26	8.94
Jan 26	6.83
Dec 25	7.2
Dec 25	7.04
Dec 25	7.24
Dec 25	7.2
Nov 25	7.04
Nov 25	7.37
Nov 25	8.11
Nov 25	6.29
Oct 25	5.38
Oct 25	5.83
Oct 25	5.65
Oct 25	4.7
Oct 25	4.84
Sep 25	4.84
Sep 25	4.93
Sep 25	5.02
Sep 25	4.88
Aug 25	5.02
Aug 25	4.98
Aug 25	5.29
Aug 25	6.65
Aug 25	6.97
Jul 25	7.47
Jul 25	7.22
Jul 25	7.4
Jul 25	7.4
Jun 25	7.03
Jun 25	6.84
Jun 25	7.34
Jun 25	7.84
May 25	9.16
May 25	9.1
May 25	9.41
May 25	9.56
May 25	9.3
Apr 25	8.31
Apr 25	7.3
Apr 25	7.15
Apr 25	6.39
Mar 25	7.1
Mar 25	6.43
Mar 25	5.24
Mar 25	6.29
Feb 25	6.72
Feb 25	9.39
Feb 25	7.44
Feb 25	7.37
Jan 25	7.8
Jan 25	8.31
Jan 25	7.66
Jan 25	7.95
Jan 25	10.62
Dec 24	7.88
Dec 24	8.02
Dec 24	8.82
Dec 24	8.89
Nov 24	10.26
Nov 24	9.9
Nov 24	10.12
Nov 24	17.6
Nov 24	17.95
Oct 24	18.41

EV/EBITDA

TXMD EV/EBITDA by year
Period	EV/EBITDA
Apr 24	0.17
Apr 24	0.17
Apr 24	0.19
Apr 24	0.21
Mar 24	0.22
Mar 24	0.22
Mar 24	0.23
Mar 24	0.22
Mar 24	0.24
Feb 24	0.21
Feb 24	0.21
Feb 24	0.22
Feb 24	0.22
Jan 24	0.22
Jan 24	0.21
Jan 24	0.22
Jan 24	0.22
Dec 23	0.21
Dec 23	0.22
Dec 23	0.22
Dec 23	0.2
Dec 23	0.26
Nov 23	0.29
Nov 23	0.21
Nov 23	0.18
Nov 23	0.2
Oct 23	0.18
Oct 23	0.21
Oct 23	0.24
Oct 23	0.28
Sep 23	0.3
Sep 23	0.3
Sep 23	0.34
Sep 23	0.37
Sep 23	0.39
Aug 23	0.42
Aug 23	0.39
Aug 23	0.41
Aug 23	0.45
Jul 23	0.41
Jul 23	0.44
Jul 23	0.4
Jul 23	0.42
Jun 23	0.43
Jun 23	0.42
Jun 23	0.39
Jun 23	0.42
Jun 23	0.47
May 23	0.39
May 23	0.45
May 23	0.2
May 23	0.11
Apr 23	0.07
Apr 23	0.1
Apr 23	0.08

Price/Operating Cashflow

TXMD Price/Operating Cashflow by year
Period	Price/Operating Cashflow
Sep 26	8.01
Sep 26	8.01
Sep 26	8.2
Aug 26	8.24
Aug 26	7.64
Aug 26	7.68
Aug 26	8.96
Jul 26	8.79
Jul 26	8.92
Jul 26	8.92
Jul 26	8.66
Jul 26	9.13
Jun 26	9.13
Jun 26	8.44
Jun 26	9.52
Jun 26	8.61
May 26	9.26
May 26	9.18
May 26	8.66
May 26	9.45
May 26	9.88
Apr 26	10.45
Apr 26	9.88
Apr 26	9.88
Apr 26	9.55
Mar 26	11.75
Mar 26	12.54
Mar 26	12.14
Mar 26	12.59
Feb 26	12.65
Feb 26	12.87
Feb 26	13.21
Feb 26	12.82
Jan 26	12.09
Jan 26	14.61
Jan 26	12.48
Jan 26	12.09
Jan 26	9.23
Dec 25	9.74
Dec 25	9.51
Dec 25	9.79
Dec 25	9.74
Nov 25	9.51
Nov 25	9.96
Nov 25	10.97
Nov 25	19.22
Oct 25	16.46
Oct 25	17.84
Oct 25	17.28
Oct 25	14.38
Oct 25	14.8
Sep 25	14.8
Sep 25	15.07
Sep 25	15.35
Sep 25	14.93
Aug 25	15.35
Aug 25	15.21
Aug 25	16.18
Aug 25	8.7
Aug 25	9.11
Jul 25	9.77
Jul 25	9.44
Jul 25	9.69
Jul 25	9.69
Jun 25	9.2
Jun 25	8.95
Jun 25	9.61
Jun 25	10.26
May 25	11.99
May 25	11.91
May 25	12.32
May 25	23
May 25	22.37
Apr 24	1.02
Apr 24	1.02
Apr 24	1.09
Apr 24	1.21
Mar 24	1.26
Mar 24	1.26
Mar 24	1.32
Mar 24	1.28
Mar 24	1.4
Feb 24	1.24
Feb 24	1.24
Feb 24	1.26
Feb 24	1.25
Jan 24	1.25
Jan 24	1.23
Jan 24	1.25
Jan 24	1.25
Dec 23	1.24
Dec 23	1.27
Dec 23	1.29
Dec 23	1.14
Dec 23	1.51
Nov 23	0.94
Nov 23	0.72
Nov 23	0.63
Nov 23	0.7
Oct 23	0.64

Price to Book

TXMD Price to Book by year
Period	Price to Book
Sep 26	0.92
Sep 26	0.92
Sep 26	0.94
Aug 26	0.95
Aug 26	0.88
Aug 26	0.88
Aug 26	0.89
Jul 26	0.87
Jul 26	0.88
Jul 26	0.88
Jul 26	0.86
Jul 26	0.91
Jun 26	0.91
Jun 26	0.84
Jun 26	0.94
Jun 26	0.85
May 26	0.92
May 26	0.91
May 26	0.86
May 26	0.85
May 26	0.89
Apr 26	0.94
Apr 26	0.89
Apr 26	0.89
Apr 26	0.86
Mar 26	0.89
Mar 26	0.94
Mar 26	0.92
Mar 26	0.95
Feb 26	0.95
Feb 26	0.97
Feb 26	1
Feb 26	0.97
Jan 26	0.91
Jan 26	1.1
Jan 26	0.94
Jan 26	0.91
Jan 26	0.7
Dec 25	0.73
Dec 25	0.72
Dec 25	0.74
Dec 25	0.73
Nov 25	0.72
Nov 25	0.75
Nov 25	0.83
Nov 25	0.59
Oct 25	0.5
Oct 25	0.55
Oct 25	0.53
Oct 25	0.44
Oct 25	0.45
Sep 25	0.45
Sep 25	0.46
Sep 25	0.47
Sep 25	0.46
Aug 25	0.47
Aug 25	0.47
Aug 25	0.5
Aug 25	0.46
Aug 25	0.48
Jul 25	0.51
Jul 25	0.5
Jul 25	0.51
Jul 25	0.51
Jun 25	0.48
Jun 25	0.47
Jun 25	0.51
Jun 25	0.54
May 25	0.63
May 25	0.63
May 25	0.65
May 25	0.62
May 25	0.6
Apr 25	0.49
Apr 25	0.43
Apr 25	0.42
Apr 25	0.38
Mar 25	0.42
Mar 25	0.38
Mar 25	0.31
Mar 25	0.37
Feb 25	0.4
Feb 25	0.55
Feb 25	0.44
Feb 25	0.43
Jan 25	0.46
Jan 25	0.49
Jan 25	0.45
Jan 25	0.47
Jan 25	0.63
Dec 24	0.46
Dec 24	0.47
Dec 24	0.52
Dec 24	0.52
Nov 24	0.6
Nov 24	0.58
Nov 24	0.6
Nov 24	0.63
Nov 24	0.65
Oct 24	0.66

No video analysis for this stock yet. Request one from our team.

News: TXMD

gurufocus.com · 11 Aug 2026

TherapeuticsMD Announces Second Quarter 2026 Financial Results

TherapeuticsMD, Inc. (âTherapeuticsMDâ or the âCompanyâ) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financia

businesswire.com · 11 Aug 2026

TherapeuticsMD Announces Second Quarter 2026 Financial Results

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the three months ended June 30, 2026. Second Quarter 2026 Financial Results Net Income from Continuing Operations Net income from continuing operations totaled $164 thousand, compared to net income of $545 thousand for the second quarter of 2025. License Revenues from Continuing Operations The Com.

AI Analysis

TherapeuticsMD, Inc.

Video analysis: TXMD

News: TXMD

TherapeuticsMD Announces Second Quarter 2026 Financial Results

TherapeuticsMD Announces Second Quarter 2026 Financial Results

Similar companies